HCPCS Level IIdrugActive
J9021
Inj, aspara, rylaze, 0.1 mg
BETOS: O1D
Effective: 2022-01-01
Description
Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rylaze
Manufacturer
Jazz Pharmaceuticals, Inc.
HCPCS Dosage
0.1 MG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.